Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes—The INTERFAST ‐3 study design | Synapse
April 18, 2026Diabetic Medicine0 citationsOpen Access
Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes—The INTERFAST ‐3 study design
To evaluate the safety and efficacy of intermittent fasting, both with and without exercise, in individuals with obesity and type 2 diabetes.
Clinical trial design registered at DRKS.
Participants include individuals diagnosed with type 2 diabetes and obesity.
Interventions involve intermittent fasting with and without exercise.
Specific outcomes on safety and efficacy to be determined after the trial.
Expect to observe changes in weight, metabolic health, and diabetes control.
Abstract
The study was registered at DRKS (Deutsches Register Klinischer Studien-German Clinical Trial Register DRKS-ID: DRKS00032036)-Date of registration: 11.10.2023.